+ All Categories
Home > Documents > Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr....

Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr....

Date post: 15-Jan-2016
Category:
View: 218 times
Download: 0 times
Share this document with a friend
Popular Tags:
26
Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt
Transcript
Page 1: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Unused MedicationsWhere are we now?

Prepared for: U.S. Drug Enforcement

Administration

By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt

July 19, 2011

Page 2: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Disclosures

• Poison Center Incentive Grant funded by HRSA

• No other potential conflicts of interest

Page 3: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Context

Page 4: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Acknowledgement

This presentation includes information collected and compiled by the

Pharmaceutical Collection Monitoring Group

through use of thePharmaceutical Collection

Monitoring System™

Page 5: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Purpose for Visit

• There’s an elephant in the room– Not that unused medications are a problem

• Now common knowledge:– Meds as a source of poisonings– Source of abuse (and diversion)– Source of misuse– Source of environmental contamination

• Finding a solution– Band aid approach is no longer enough

• Take back events are a band aid approach

Page 6: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Root Cause Analysis is Needed

1. Define the problem factually2. Gather data and evidence3. Ask “why” and identify causes4. Identify corrective actions that will prevent

recurrence5. Implement actions6. Observe effect

Page 7: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Purpose for Visit

• We’ve hit a brick wall at step #2 (gather data and evidence)

• We need the help of the DEA• Outline

– Discuss successful collection events– Data utility– Share results– Request support

Page 8: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Data Collection

• Numerous take backs across country• Several high-quality data sets

– Gressitt– Mireles– Gottlieb– Jaramillo

• All data sets collected different data points– No consistency– Merging of data difficult if not impossible

Page 9: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Pharmaceutical Collection Monitoring System™ (PCMS)

• Web-based recording and reporting tool• Provides for collection of consistent data

across multiple sites• Accessible by users anywhere that internet

service is available

Page 10: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

A Case Report: Car #188

• Amarillo, Texas • Population: ~180,000• Community Medication Take Back Event• Drive through• Collaborative effort with Amarillo Police

Department

Page 11: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Car #188

Page 12: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Car #188

• 2 large boxes• Medications from deceased parents

and cat• Speculatively parents both suffered

from chronic, terminal diseases• Reporting today only the controlled

substances from this vehicle

Page 13: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.
Page 14: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Controlled Substances from Car #188

Drug Name Strength # ContainersQty

Collected AWPLow-High End

Street Value

diazepam 5 mg 18 2,320 $167 $2,320 - $46,400hydrocodone/ APAP 10/325 mg 4 520 $363 $1,040 - $10,400

Lorcet® 5/500 mg 2 2 $3 $6 - $18

Lyrica® 75 mg 6 84 $227 $420 - $1,680

morphine sulfate 30 mg 61 10,080 $5,352 $80,640 - $302,400

MS Contin® 30 mg 3 6 $17 $90 - $300

oxycodone/APAP 5/500 mg 15 802 $95 $802 - $4,010

temazepam 30 mg 2 180 $32 $180 - $3,600

111 13,994 $6,256 $85,498 - $368,808

Values obtained from NDIC reports. Indicate estimates.

Page 15: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Car #188

• Rare occurrence or more common than we think?

• No data • Of what use would the data be? Would it

really help anything?

Page 16: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

What data do we have?

Page 17: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

April 30th DEA Take Back Day

• Eight organizations• 11 sites• Conducted events and logged data• Goal: data from at least first 50 participants• Result: data from items of 411 participants

was collected• 3,800 line items logged

Page 18: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

April 30th DEA Take Back Day

6%

60%

33%

Percentage Collected by Classification - All Sites Combined

Controlled Substances

Non-Controlled Substances

Over-the-counters

Unknown/unidentified

Page 19: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.
Page 20: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Most Commonly Collected Controls

Acetaminophen with hydrocodone 22.7%

Acetaminophen with propoxyphene 21.3%

Benzodiazepines11.3%

Page 21: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

By Schedule

See handout report• C II• C III• C IV• C V

Page 22: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Medication Utilization/ Wastage

• Controlled substances collected/documented– On average, 67% of dispensed controls were

brought to take back events for disposal– 67% = wasted

• Overprescribed?• Over-marketed?

60% 20%

18%

10%

*total >100% as some participants selected >1 answer

Percentages indicate what event participants would do with meds if event was unavailable.

Page 23: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Why come to the DEA

• Data has utility; greatly needed• Lost participation of sites due to lack of DEA

support• Current directives

– No questions– No counts– No handling of meds

Page 24: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Why come to the DEA?

• Need DEA to be part of the solution– Funding? – Letter of support?– Letter of understanding?

Page 25: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Academia

PCMS

Community Partners.

Local Law Enforcement

.

DEA

Page 26: Unused Medications Where are we now? Prepared for: U.S. Drug Enforcement Administration By: Dr. Jeanie Jaramillo and Dr. Stevan Gressitt July 19, 2011.

Contact Information

Jeanie [email protected](806) 354-1611

Stevan [email protected]

(207)441-0291


Recommended